OTCMKTS:CRLBF Cresco Labs (CRLBF) Stock Price, News & Analysis → Elon Musk’s Controversial New Project: “Apollo” (From InvestorPlace) (Ad) Free CRLBF Stock Alerts $2.01 +0.03 (+1.52%) (As of 04/23/2024 ET) Add Compare Share Share Today's Range$1.95▼$2.0550-Day Range$1.52▼$2.3052-Week Range$1.00▼$2.77Volume226,492 shsAverage Volume746,768 shsMarket Capitalization$694.70 millionP/E RatioN/ADividend YieldN/APrice Target$20.33 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get Cresco Labs alerts: Email Address Cresco Labs MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside911.6% Upside$20.33 Price TargetShort InterestHealthy0.52% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.25Based on 6 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.07) to ($0.04) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.46 out of 5 stars 3.3 Analyst's Opinion Consensus RatingCresco Labs has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageCresco Labs has only been the subject of 2 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.52% of the outstanding shares of Cresco Labs have been sold short.Short Interest Ratio / Days to CoverCresco Labs has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cresco Labs has recently increased by 1.22%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldCresco Labs does not currently pay a dividend.Dividend GrowthCresco Labs does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CRLBF. Previous Next 2.1 News and Social Media Coverage News SentimentCresco Labs has a news sentiment score of -0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.44 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Cresco Labs this week, compared to 2 articles on an average week.Search Interest11 people have searched for CRLBF on MarketBeat in the last 30 days. MarketBeat Follows18 people have added Cresco Labs to their MarketBeat watchlist in the last 30 days. This is an increase of 64% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cresco Labs insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.05% of the stock of Cresco Labs is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Cresco Labs are expected to grow in the coming year, from ($0.07) to ($0.04) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cresco Labs is -3.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cresco Labs is -3.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCresco Labs has a P/B Ratio of 1.62. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad InvestorPlaceElon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...Click here to see the details because there's a lot of money at stake. About Cresco Labs Stock (OTCMKTS:CRLBF)Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.Read More CRLBF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CRLBF Stock News HeadlinesApril 23, 2024 | msn.comNANX Stock Earnings: Nanophase Technologies Reported Results for Q1 2024April 23, 2024 | americanbankingnews.comCresco Labs (OTCMKTS:CRLBF) Stock Price Down 1%April 24, 2024 | InvestorPlace (Ad)Elon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...April 18, 2024 | benzinga.comCannabis Chart Of The Week: How Much Have MSO Valuation Multiples Changed In The Last Year And Why?April 17, 2024 | msn.comMarijuana banking unlikely to pass House due to Republican leadership spatApril 17, 2024 | fool.comThe Best Cannabis Stock to Invest $1,000 in Right NowApril 9, 2024 | markets.businessinsider.comJefferies Remains a Buy on Cresco Labs (CRLBF)March 28, 2024 | msn.com2 Marijuana Companies That Have Recently Turned ProfitsApril 24, 2024 | InvestorPlace (Ad)Elon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...March 27, 2024 | investorplace.com3 Cannabis Stocks to Buy Before the Coming Pre-Election RallyMarch 20, 2024 | msn.comCresco vs. Tilray: Which Cannabis Stock Is a Better Buy?March 18, 2024 | investorplace.comCRLBF Stock Earnings: Cresco Labs Beats EPS, Beats Revenue for Q4 2023March 15, 2024 | morningstar.comCresco Labs' stock rallies as cannabis company swings to a profitMarch 15, 2024 | seekingalpha.comCresco Labs Inc. (CRLBF) Q4 2023 Earnings Call TranscriptMarch 13, 2024 | markets.businessinsider.comNeedham Keeps Their Hold Rating on Cresco Labs (CRLBF)March 13, 2024 | markets.businessinsider.comCresco Labs Turns To Profit In Q4March 13, 2024 | msn.comCresco Labs’ stock rallies as cannabis company swings to a profitMarch 13, 2024 | businesswire.comCresco Labs Reports Fourth Quarter & Full Year 2023 Financial Results Demonstrating Significant Profitability and Cash Flow ImprovementsFebruary 27, 2024 | businesswire.comCresco Labs to Report Fourth Quarter and Annual 2023 Financial Results on March 13, 2024February 24, 2024 | benzinga.comCannabis Stocks Jump As Germany Legalizes Marijuana PossessionFebruary 23, 2024 | businesswire.comCresco Labs Continues Retail Expansion in Pennsylvania with New Gettysburg StoreFebruary 21, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Cresco Labs (OtherCRLBF), Medios AG (OtherMEDOF) and Bayer (GB:0P6S)February 20, 2024 | benzinga.comTop Cannabis Appointments You Should Know About: Aurora's New CFO And Other ChangesFebruary 18, 2024 | investorplace.comCannabis Comeback: 3 Stocks to Snag After the Bubble BurstFebruary 9, 2024 | morningstar.comCresco Labs Inc CRLBFFebruary 9, 2024 | finance.yahoo.comCresco Labs Announces Transfers of Super Voting Shares to Certain DirectorsFebruary 9, 2024 | businesswire.comCresco Labs Announces Transfers of Super Voting Shares to Certain DirectorsSee More Headlines Receive CRLBF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/15/2024Today4/24/2024Next Earnings (Estimated)5/22/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medicinals & botanicals Sub-IndustryN/A Current SymbolOTCMKTS:CRLBF CUSIPN/A CIK1832928 Webwww.crescolabs.com Phone312-929-0993FaxN/AEmployees2,760Year FoundedN/APrice Target and Rating Average Stock Price Target$20.33 High Stock Price Target$34.00 Low Stock Price Target$2.00 Potential Upside/Downside+911.6%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.54) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-175,520,000.00 Net Margins-22.77% Pretax Margin-19.06% Return on Equity-10.51% Return on Assets-3.56% Debt Debt-to-Equity Ratio1.55 Current Ratio1.39 Quick Ratio0.85 Sales & Book Value Annual Sales$770.89 million Price / Sales0.90 Cash Flow$0.05 per share Price / Cash Flow39.31 Book Value$1.24 per share Price / Book1.62Miscellaneous Outstanding Shares345,620,000Free FloatN/AMarket Cap$694.70 million OptionableNot Optionable Beta2.29 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Charles Bachtell (Age 45)Co-Founder, CEO & Director Comp: $999.85kMr. Robert M. Sampson (Age 49)Co-Founder & Independent Director Mr. Dennis M. Olis (Age 61)Chief Financial Officer Comp: $622.85kMr. Gregory Butler (Age 43)President & Chief Transformation Officer Mr. Ty Gent (Age 65)Chief Operating Officer Mr. Zach Marburger (Age 39)Chief Information Officer Ms. Megan KulickSenior Vice President of Investor RelationsMr. John Schetz (Age 46)General Counsel Mr. Jason Erkes (Age 53)Chief Communications Officer Ms. Angie Demchenko (Age 43)Chief People Officer More ExecutivesKey CompetitorsMind Medicine (MindMed)NASDAQ:MNMDCanopy GrowthNASDAQ:CGCUSANA Health SciencesNYSE:USNACronos GroupNASDAQ:CRONbioteNASDAQ:BTMDView All Competitors CRLBF Stock Analysis - Frequently Asked Questions Should I buy or sell Cresco Labs stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CRLBF shares. View CRLBF analyst ratings or view top-rated stocks. What is Cresco Labs' stock price target for 2024? 3 equities research analysts have issued 12 month price objectives for Cresco Labs' shares. Their CRLBF share price targets range from $2.00 to $34.00. On average, they predict the company's share price to reach $20.33 in the next year. This suggests a possible upside of 911.6% from the stock's current price. View analysts price targets for CRLBF or view top-rated stocks among Wall Street analysts. How have CRLBF shares performed in 2024? Cresco Labs' stock was trading at $1.3558 on January 1st, 2024. Since then, CRLBF stock has increased by 48.3% and is now trading at $2.01. View the best growth stocks for 2024 here. Are investors shorting Cresco Labs? Cresco Labs saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 1,759,900 shares, an increase of 28.7% from the February 29th total of 1,367,000 shares. Based on an average daily volume of 1,481,600 shares, the days-to-cover ratio is currently 1.2 days. View Cresco Labs' Short Interest. When is Cresco Labs' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 22nd 2024. View our CRLBF earnings forecast. How were Cresco Labs' earnings last quarter? Cresco Labs Inc. (OTCMKTS:CRLBF) released its earnings results on Friday, March, 15th. The company reported $0.01 EPS for the quarter, beating the consensus estimate of ($0.02) by $0.03. The company earned $188.24 million during the quarter, compared to analysts' expectations of $181.36 million. Cresco Labs had a negative net margin of 22.77% and a negative trailing twelve-month return on equity of 10.51%. How do I buy shares of Cresco Labs? Shares of CRLBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CRLBF) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cresco Labs Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
